CT Tumor Volume Measurement in Advanced Non-small-cell Lung Cancer
- 1 November 2010
- journal article
- research article
- Published by Elsevier in Academic Radiology
- Vol. 18 (1) , 54-62
- https://doi.org/10.1016/j.acra.2010.08.021
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Evaluating Variability in Tumor Measurements from Same-day Repeat CT Scans of Patients with Non–Small Cell Lung CancerRadiology, 2009
- Pulmonary Nodules: Volume Repeatability at Multidetector CT Lung Cancer ScreeningRadiology, 2009
- Noncalcified Lung Nodules: Volumetric Assessment with Thoracic CTRadiology, 2009
- Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2007
- CT Evaluation of the Response of Gastrointestinal Stromal Tumors After Imatinib Mesylate Treatment: A Quantitative Analysis Correlated with FDG PET FindingsAmerican Journal of Roentgenology, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986